Silverarc Capital Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-93,700
| Closed | -$625K | – | 87 |
|
|
2023
Q3 | $625K | Hold |
93,700
| – | – | 0.19% | 57 |
|
|
2023
Q2 | $849K | Sell |
93,700
-104,777
| -53% | -$949K | 0.26% | 59 |
|
|
2023
Q1 | $1.44M | Sell |
198,477
-202,335
| -50% | -$1.47M | 0.6% | 45 |
|
|
2022
Q4 | $2.92M | Buy |
400,812
+100,812
| +34% | +$735K | 0.84% | 36 |
|
|
2022
Q3 | $2.32M | Buy |
+300,000
| New | +$2.32M | 0.78% | 35 |
|
|
2022
Q2 | – | Sell |
-204,679
| Closed | -$1.63K | – | 78 |
|
|
2022
Q1 | $1.63K | Buy |
204,679
+217
| +0.1% | +$2 | 0.67% | 36 |
|
|
2021
Q4 | $1.15M | Buy |
204,462
+132,733
| +185% | +$743K | 0.46% | 57 |
|
|
2021
Q3 | $552K | Buy |
+71,729
| New | +$552K | 0.31% | 62 |
|
|
2021
Q2 | – | Sell |
-40,000
| Closed | -$420K | – | 116 |
|
|
2021
Q1 | $420K | Buy |
40,000
+991
| +3% | +$10.4K | 0.23% | 75 |
|
|
2020
Q4 | $543K | Buy |
+39,009
| New | +$543K | 0.32% | 69 |
|